A group of advisers to the Food and Drug Administration voted in favor of allowing pharmacies to compound peptides like BPC-157 and TB-500, which means the hot-button peptides may soon become more broadly available to Americans
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism
Mechanisms relevant to psoriasis: Reduces NF-B activity (a key inflammatory pathway in psoriasis) Decreases pro-inflammatory cytokines Promotes collagen synthesis and skin remodeling Activates wound healing gene expression Anti-oxidant properties reduce oxidative stress in lesions Research highlight: GHK-Cu has been shown to reset gene expression patterns associated with aging and inflammation
5-Amino-1MQ is squarely focused on the NAD+ salvage pathway
Grubb prescribes peptide therapy to treat various musculoskeletal conditions, including: Disc herniation (herniated intervertebral discs) Back pain Neck pain Cervical spinal stenosis (narrowing of the spinal canal in the neck) Lumbar spinal stenosis (narrowing of the spinal canal in the lower back) Radiculopathy (nerve compression/irritation) Peptide therapy is quick, pain-free, and significantly less risky than minimally invasive and open spine surgery
FDAs 2026 Assessment FDA stated that BPC-157 is not well characterised from a physicochemical perspective and that multiple forms have been marketed under the same common name
